USA - NASDAQ:MMSI - US5898891040 - Common Stock
The current stock price of MMSI is 78.99 USD. In the past month the price decreased by -7.65%. In the past year, price decreased by -16.28%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ALC | ALCON INC | 23.86 | 36.00B | ||
COO | COOPER COS INC/THE | 17.01 | 13.59B | ||
SOLV | SOLVENTUM CORP | 11.6 | 12.23B | ||
ALGN | ALIGN TECHNOLOGY INC | 13.37 | 9.12B | ||
BLCO | BAUSCH + LOMB CORP | 34.1 | 5.07B | ||
LNTH | LANTHEUS HOLDINGS INC | 8.38 | 3.64B | ||
ICUI | ICU MEDICAL INC | 15.18 | 2.82B | ||
XRAY | DENTSPLY SIRONA INC | 6.92 | 2.36B | ||
HAE | HAEMONETICS CORP/MASS | 10.51 | 2.35B | ||
UFPT | UFP TECHNOLOGIES INC | 22.17 | 1.48B | ||
STAA | STAAR SURGICAL CO | N/A | 1.32B | ||
NEOG | NEOGEN CORP | 20.13 | 1.31B |
Merit Medical Systems, Inc. engages in the manufacture and marketing of proprietary disposable medical devices. The company is headquartered in South Jordan, Utah and currently employs 7,400 full-time employees. Its cardiovascular segment consists of four product categories: peripheral intervention, cardiac intervention, custom procedural solutions, and original equipment manufacturer. Its endoscopy segment consists of gastroenterology and pulmonology devices which assist in the palliative treatment of expanding esophageal, tracheobronchial and biliary strictures caused by malignant tumors. Its product portfolio of medical devices and accessories is used in lead management procedures for patients who need a pacemaker, or an implantable cardioverter-defibrillator lead removed or replaced. Its products are used in clinical areas, such as radiology, electrophysiology and more. The company also manufactures hemostatic devices under the brand names StatSeal and WoundSeal.
MERIT MEDICAL SYSTEMS INC
1600 West Merit Park Way
South Jordan UTAH 84095 US
CEO: Fred P. Lampropoulos
Employees: 7400
Phone: 18012531600
The current stock price of MMSI is 78.99 USD. The price decreased by -4.23% in the last trading session.
The exchange symbol of MERIT MEDICAL SYSTEMS INC is MMSI and it is listed on the Nasdaq exchange.
MMSI stock is listed on the Nasdaq exchange.
17 analysts have analysed MMSI and the average price target is 106.49 USD. This implies a price increase of 34.81% is expected in the next year compared to the current price of 78.99. Check the MERIT MEDICAL SYSTEMS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
MERIT MEDICAL SYSTEMS INC (MMSI) has a market capitalization of 4.68B USD. This makes MMSI a Mid Cap stock.
MERIT MEDICAL SYSTEMS INC (MMSI) currently has 7400 employees.
MERIT MEDICAL SYSTEMS INC (MMSI) has a support level at 78.98 and a resistance level at 84.21. Check the full technical report for a detailed analysis of MMSI support and resistance levels.
The Revenue of MERIT MEDICAL SYSTEMS INC (MMSI) is expected to grow by 10.87% in the next year. Check the estimates tab for more information on the MMSI EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
MMSI does not pay a dividend.
MERIT MEDICAL SYSTEMS INC (MMSI) will report earnings on 2025-10-30, after the market close.
The PE ratio for MERIT MEDICAL SYSTEMS INC (MMSI) is 21.58. This is based on the reported non-GAAP earnings per share of 3.66 and the current share price of 78.99 USD. Check the full fundamental report for a full analysis of the valuation metrics for MMSI.
The outstanding short interest for MERIT MEDICAL SYSTEMS INC (MMSI) is 5.57% of its float. Check the ownership tab for more information on the MMSI short interest.
ChartMill assigns a fundamental rating of 6 / 10 to MMSI. Both the health and profitability get an excellent rating, making MMSI a very profitable company, without any liquidiy or solvency issues.
Over the last trailing twelve months MMSI reported a non-GAAP Earnings per Share(EPS) of 3.66. The EPS increased by 12.62% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 8.31% | ||
ROA | 4.61% | ||
ROE | 8.01% | ||
Debt/Equity | 0.49 |
17 analysts have analysed MMSI and the average price target is 106.49 USD. This implies a price increase of 34.81% is expected in the next year compared to the current price of 78.99.
For the next year, analysts expect an EPS growth of 5.69% and a revenue growth 10.87% for MMSI